• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Clin Pract . Association between different screening strategies for SARS-CoV-2 and deaths and severe disease in Italy

tetano

Editor, Senior Moderator
Int J Clin Pract


. 2020 Nov 24;e13867.
doi: 10.1111/ijcp.13867. Online ahead of print.
Association between different screening strategies for SARS-CoV-2 and deaths and severe disease in Italy


Edoardo Mannucci[SUP] 1 [/SUP], Antonio Silverii[SUP] 1 [/SUP], Matteo Monami[SUP] 1 [/SUP]



Affiliations

Abstract

Background: The WHO recommends testing any suspected person with Severe Acute Respiratory Syndrome CoronaVirus-2 (SARS-CoV-2), in order to limit the spread of the epidemic. In Italy, some Regions opted for extensive testing, whereas others limited tests to selected subjects. To assess the influence of different strategies, we examined the incidence of death and severe cases in Italy.
Methods: Data on new cases of SARS-CoV-2, number of tests, deaths, and admissions to Intensive Care Units (ICU) were retrieved in each Italian Region, from February 24[SUP]th[/SUP] to March 18[SUP]th[/SUP] , 2020. As an index of different screening strategies, the number of tests/positive test results (P/T) ratio as of March 7[SUP]th[/SUP] , 2020, was considered. The cumulative number of deaths and of new severe cases, between March 23[SUP]th[/SUP] and 25[SUP]th[/SUP] was recorded. The association of those two outcomes with the number of P/T ratio was assessed using linear regression models.
Results: In the interval between March 23[SUP]th[/SUP] -25[SUP]th[/SUP] , recorded deaths (*million inhabitants) were 14(3-54), whereas severe cases were 31(10-112). Both the number of deaths and that of severe cases showed a significant correlation (R[SUP]2[/SUP] .57 and .41, with p<.01) with the P/T ratio. Deaths and severe cases were associated with higher mean personal income and lower density of General Practioners (GPs). The association of P/T with severe cases and deaths retained statistical significance after adjusting for mean personal income (R[SUP]2[/SUP] .30 and .41, respectively; both p=.04) and GPs density (R[SUP]2[/SUP] .21 and .19, respectively; both p=.03).
Conclusions: A more aggressive screening strategy for SARS-Cov-2, was associated with lower rates of death and severe disease in Regions of Italy.

Keywords: COVID-19; SARS-Cov-2; death; severe case.
 
Back
Top Bottom